@article{8a2a6ba7bb5f4d34ad256140b8d64b7e,
title = "The expanding clinical phenotype of germline ABL1-associated congenital heart defects and skeletal malformations syndrome",
abstract = "Congenital heart defects and skeletal malformations syndrome (CHDSKM) is a rare autosomal dominant disorder characterized by congenital heart disease, skeletal abnormalities, and failure to thrive. CHDSKM is caused by germline mutations in ABL1. To date, three variants have been in association with CHDSKM. In this study, we describe three de novo missense variants, c.407C>T (p.Thr136Met), c.746C>T (p.Pro249Leu), and c.1573G>A (p.Val525Met), and one recurrent variant, c.1066G>A (p.Ala356Thr), in six patients, thereby expanding the phenotypic spectrum of CHDSKM to include hearing impairment, lipodystrophy-like features, renal hypoplasia, and distinct ocular abnormalities. Functional investigation of the three novel variants showed an increased ABL1 kinase activity. The cardiac findings in additional patients with p.Ala356Thr contribute to the accumulating evidence that patients carrying either one of the recurrent variants, p.Tyr245Cys and p.Ala356Thr, have a high incidence of cardiac abnormalities. The phenotypic expansion has implications for the clinical diagnosis of CHDSKM in patients with germline ABL1 variants.",
keywords = "CHDSKM, congenital heart defects, hearing impairment, renal hypoplasia, skeletal malformations",
author = "Chun-An Chen and Emeline Crutcher and Harinder Gill and Nelson, {Tanya N} and Robak, {Laurie A} and Jongmans, {Marjolijn C J} and Rolph Pfundt and Chitra Prasad and Berard, {Roberta A} and Madeleine Fannemel and Eirik Frengen and Doriana Misceo and Keri Ramsey and Yaping Yang and Schaaf, {Christian P} and Xia Wang",
note = "Funding Information: The authors sincerely thank all the family members for their participation in this study. This study was supported by the departmental fund from the Department of Molecular and Human Genetics at Baylor College of Medicine. The investigators of the CAUSES Study include Shelin Adam, Christele Du Souich, Alison Elliott, Anna Lehman, Jill Mwenifumbo, Tanya Nelson, Clara Van Karnebeek, and Jan Friedman. CAUSES Study is funded by Mining for Miracles, British Columbia Children's Hospital Foundation and Genome British Columbia. The investigators of the C4RCD Research Group include Chris Balak, Newell Belnap, Amanda Courtright‐Lim, David Craig, Matthew Huentelman, Wayne Jepsen, Lori Llaci, Marcus Naymik, Ignazio Piras, Sampathkumar Rangasamy, Meredith Sanchez‐Castillo, Szabolics Szelinger, and Morgan Wolfgang. The genome sequencing service of Patient 5 was performed by the Norwegian High‐Throughput Sequencing Centre, a national technology platform supported by the “Functional Genomics” and the “infrastructure” programs of the Research Council of Norway and the Southeastern Regional Health Authorities. Publisher Copyright: {\textcopyright} 2020 Wiley Periodicals LLC Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = oct,
doi = "10.1002/humu.24075",
language = "English",
volume = "41",
pages = "1738--1744",
journal = "Human mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "10",
}